BOCHICCHIO, MARIA TERESA
 Distribuzione geografica
Continente #
NA - Nord America 171
EU - Europa 90
AS - Asia 16
OC - Oceania 5
AF - Africa 4
SA - Sud America 4
Totale 290
Nazione #
US - Stati Uniti d'America 166
IT - Italia 33
FR - Francia 19
DE - Germania 9
BG - Bulgaria 6
GB - Regno Unito 6
CA - Canada 5
KR - Corea 4
AU - Australia 3
CN - Cina 3
EG - Egitto 3
IN - India 3
RU - Federazione Russa 3
BR - Brasile 2
CH - Svizzera 2
CL - Cile 2
IE - Irlanda 2
JP - Giappone 2
MY - Malesia 2
NL - Olanda 2
NZ - Nuova Zelanda 2
TR - Turchia 2
CZ - Repubblica Ceca 1
ES - Italia 1
FI - Finlandia 1
GR - Grecia 1
HU - Ungheria 1
PL - Polonia 1
SE - Svezia 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 290
Città #
Fairfield 14
Santa Cruz 14
Seattle 10
Woodbridge 10
Ashburn 9
Bologna 8
Buffalo 8
Cedar Knolls 7
Chicago 6
Sofia 6
Cambridge 5
Boardman 4
Houston 4
Milan 4
Wilmington 4
Alexandria 3
Boston 3
Henderson 3
Los Angeles 3
Nizhniy Novgorod 3
Ankara 2
Ann Arbor 2
Bari 2
Christchurch 2
Dallas 2
Dublin 2
Frankfurt Am Main 2
Munich 2
New York 2
Ottawa 2
Recife 2
Rome 2
Tokyo 2
Yuma 2
Angri 1
Atlanta 1
Beijing 1
Büdelsdorf 1
Cesena 1
Clearwater 1
Cologne 1
Faenza 1
Florence 1
Forlì 1
Guangzhou 1
Herndon 1
Hillsboro 1
Imola 1
Lake Forest 1
Lappeenranta 1
Las Vegas 1
Laval 1
Lossiemouth 1
Lucerne 1
Manchester 1
Mandello del Lario 1
Milpitas 1
Miri 1
Muizenberg 1
Norwalk 1
Nuremberg 1
Paris 1
Pasadena 1
Phoenix 1
Pieve di Cento 1
Provo 1
Redmond 1
Riva 1
Santiago 1
Seoul 1
Seri Kembangan 1
Southend 1
Tewkesbury 1
Toronto 1
Tyresö 1
University Park 1
Waldoboro 1
Wuhan 1
Zurich 1
Totale 201
Nome #
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes, file e1dcb333-6585-7715-e053-1705fe0a6cc9 139
Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients., file e1dcb32e-cf5e-7715-e053-1705fe0a6cc9 58
Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients, file a4a028ea-739e-40fd-a04d-b69c4aad3f64 33
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia, file e1dcb337-384e-7715-e053-1705fe0a6cc9 14
Digital PCR (dPCR) Overcomes the Limitations in Detection and in Quantification of Quantitative PCR (qPCR) and Reveals Different Levels of BCR-ABL1 Copies/µl Among the Chronic Myeloid Leukemia (CML) Patients Achieving Major (MR3.0) or DEEP (MR4.0, MR4.5 and MR5.0) Molecular Response with Tyrosin Kynase Inhibitors (TKIs), file e1dcb331-0af5-7715-e053-1705fe0a6cc9 10
Kevetrin induces apoptosis in TP53 wild-type and mutant acute myeloid leukemia cells, file f7fc7aae-1432-4254-9ef2-8a75a860f23b 8
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR), file e1dcb330-ea71-7715-e053-1705fe0a6cc9 7
Kevetrin induces apoptosis in TP53 wild-type and mutant acute myeloid leukemia cells, file 9e90317f-1844-419a-93d7-853ed25f152a 6
Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients, file f731c299-fdbc-444b-a8c4-6b346fb4fa29 6
ETV6::ABL1-Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment, file 3e24a95e-b0cc-4fad-b685-beebaa51868d 4
Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: Molecular cytogenetic characterization and influence on TKIs therapy, file e1dcb330-c14f-7715-e053-1705fe0a6cc9 4
Evaluation of Cepheid Xpert® BCR-ABL Monitor Assay in Three Italian Reference Centers for Monitoring of BCR-ABL Transcript Levels in CML Patients, file e1dcb330-c2db-7715-e053-1705fe0a6cc9 4
One-Step Quantitative Molecular Approach for Detection of BCR/ABL1 Rearrangement and for Monitoring of Minimal Residual Disease in CML Patients: An Inter Laboratory Study, file e1dcb330-fdbf-7715-e053-1705fe0a6cc9 4
Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations, file cf0d0844-bb0a-4b58-8baa-4d229a4ed600 2
null, file e1dcb32e-ddc7-7715-e053-1705fe0a6cc9 1
Totale 300
Categoria #
all - tutte 995
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 995


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202035 0 0 0 0 0 0 2 5 9 5 5 9
2020/202156 5 13 1 3 7 4 4 3 6 0 7 3
2021/202262 8 6 4 5 3 2 4 4 1 1 20 4
2022/202376 2 7 14 10 7 6 6 7 7 3 6 1
2023/202471 0 0 9 8 13 13 5 7 7 8 1 0
Totale 300